Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Mousa

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|March 3, 2012
Current and future treatment of pulmonary hypertensionS Pabani, S A Mousa
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1991
Myocardial cytoprotective efficacy of azapropazone in a swine model of regional myocardial ischemia/reperfusion injuryS A Mousa, R Ritger
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Overview: from heparin to low molecular weight heparin: beyond anticoagulationS A Mousa, J Fareed
International Angiology : a Journal of the International Union of Angiology|May 7, 2005
Pharmacodynamic effects of low molecular weight heparin in obese subjects following subcutaneous administration of 75 IU/kg on plasma tissue factor pathway inhibitor and nitric oxideS A Mousa, K Johansen
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyondK Konstantopoulos, S A Mousa
General and Comparative Endocrinology|March 20, 1999
Immunocytochemical study on the localization and distribution of the somatolactin cells in the pituitary gland and the brain of Oreochromis niloticus (Teleostei, cichlidae)M A Mousa, S A Mousa
Nuclear Medicine Communications|October 1, 1991
Comparative assessment of experimental myocardial infarction with 99Tcm-hexakis-t-butyl-isonitrile (sestamibi), 111In-antimyosin and 201TlB A Khaw, S A Mousa
Cardiology|January 1, 1991
Detection sensitivity of coronary artery stenosis by 99mTc-sestamibi and 201T1 in canine models of partial and subcritical stenosisS A Mousa, J M Cooney
Drugs of Today (Barcelona, Spain : 1998)|February 14, 2014
Riociguat for the management of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionN E Larche, S A Mousa
Thrombosis Research|October 5, 2001
Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastographyS A Mousa, M S Forsythe
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Drugs of Today (Barcelona, Spain : 1998)|March 3, 2012
Current and future treatment of pulmonary hypertensionS Pabani, S A Mousa
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1991
Myocardial cytoprotective efficacy of azapropazone in a swine model of regional myocardial ischemia/reperfusion injuryS A Mousa, R Ritger
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Overview: from heparin to low molecular weight heparin: beyond anticoagulationS A Mousa, J Fareed
International Angiology : a Journal of the International Union of Angiology|May 7, 2005
Pharmacodynamic effects of low molecular weight heparin in obese subjects following subcutaneous administration of 75 IU/kg on plasma tissue factor pathway inhibitor and nitric oxideS A Mousa, K Johansen
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyondK Konstantopoulos, S A Mousa
General and Comparative Endocrinology|March 20, 1999
Immunocytochemical study on the localization and distribution of the somatolactin cells in the pituitary gland and the brain of Oreochromis niloticus (Teleostei, cichlidae)M A Mousa, S A Mousa
Nuclear Medicine Communications|October 1, 1991
Comparative assessment of experimental myocardial infarction with 99Tcm-hexakis-t-butyl-isonitrile (sestamibi), 111In-antimyosin and 201TlB A Khaw, S A Mousa
Cardiology|January 1, 1991
Detection sensitivity of coronary artery stenosis by 99mTc-sestamibi and 201T1 in canine models of partial and subcritical stenosisS A Mousa, J M Cooney
Drugs of Today (Barcelona, Spain : 1998)|February 14, 2014
Riociguat for the management of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionN E Larche, S A Mousa
Thrombosis Research|October 5, 2001
Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastographyS A Mousa, M S Forsythe
Pageof 14